Florida is rapidly emerging as one of the nation’s most important hubs for medical technology innovation. In this conversation, leaders from companies shaping Florida’s MedTech Triangle, including Stryker, Quest Diagnostics and others, join BioFlorida President Mark Glickman to explore the forces driving the state’s growing influence in life sciences. From advanced manufacturing and product development to talent pipelines and global market expansion, the panel examines how Florida’s unique convergence of industry, research institutions, and policy leadership is accelerating innovation. The discussion offers a strategic look at how MedTech companies are building, scaling, and investing in Florida, and what it means for the future of the state’s life sciences ecosystem.
Speakers
Who you'll hear from
Start Date
End Date
Location
eMerge HEALTH Stage
Topics
Tech for Enterprise, Florida Innovation, Healthtech
